NeurAsia Sdn Bhd is a physician-led full-service clinical research organisation (CRO) dedicated to advancing high-quality, efficient, and compliant multinational clinical trials through science-driven expertise and continuous innovation. Led by experienced clinicians and industry experts, the company brings together strong capabilities in clinical research, trial design, regulatory compliance, pharmacovigilance, and clinical operations. While specialising in neurological and psychiatric disorders such as Alzheimer’s disease, dementia, depression, motor neuron disease, multiple sclerosis, and pain management, NeurAsia also supports clinical trials across a broad range of therapeutic areas including cardiology and oncology. By integrating AI-driven automation into clinical workflows, NeurAsia enhances speed, efficiency, and data quality to accelerate the development of innovative treatments globally.